Dr. Smythe’s presentation, which is included in the Conference’s “Emerging Markets Track,” is scheduled for Wednesday, January 9, 2019 at 3:00 p.m. Pacific Time.
| BOULDER, Colo., Jan. 2, 2019 /PRNewswire/ -- Somalogic, Inc., announced today that its new Chief Executive Officer, Roy Smythe, M.D., will present the company’s current status and strategic direction at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco, California. Dr. Smythe’s presentation, which is included in the Conference’s “Emerging Markets Track,” is scheduled for Wednesday, January 9, 2019 at 3:00 p.m. Pacific Time.
For further information or to set up an interview with Dr. Smythe or other SomaLogic leaders during or after the Conference, please contact Laura Mizoue (see below). About SomaLogic SomaLogic seeks to empower a healthier world by delivering actionable health-management insights for every seeker and enabler of human health. These essential insights, which are provided through a global network of partners and users, are derived from SomaLogic’s unique ability to measure changes in thousands of individual human proteins over time with high precision, sensitivity and throughput. For more information, visit www.somalogic.com and follow @somalogic on Twitter. Contact Information Laura Mizoue, Ph.D.
SOURCE SomaLogic, Inc. |
View original content to download multimedia:
